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A hybrid modular polyketide synthase obtained by domain swapping 
Markiyan Oliynykl, Murray JB Brown2, Jestis Cort&l, James Staunton2 
and Peter F Leadlay’ 
Background: Modular polyketide synthases govern the synthesis of a number of 
medically important antibiotics, and there is therefore great interest in 
understanding how genetic manipulation may be used to produce hybrid 
synthases that might synthesize novel polyketides. In particular, we aimed to 
show whether an individual domain can be replaced by a comparable domain 
from a different polyketide synthase to form a functional hybrid enzyme. To 
simplify the analysis, we have used our previously-developed model system 
DEBSI -TE, consisting of the first two chain-extension modules of the 
erythromycin-producing polyketide synthase of Saccharopolyspora eryfhraea. 
Results: We show here that replacing the entire acyltransferase (AT) domain 
from module 1 of DEBSl -TE by the AT domain from module 2 of the rapamycin- 
producing polyketide synthase leads, as predicted, to the synthesis of two novel 
triketide lactones in good yield, in place of the two lactones produced by 
DEBSI -TE. Both of the novel products specifically lack a methyl group at C-4 of 
the lactone ring. 
Conclusions: Although the AT domain is a core structural domain of a modular 
polyketide synthase, it has been swapped to generate a truly hybrid multienzyme 
with a rationally altered specificity of chain extension. Identical manipulations 
carried out on known polyketide antibiotics might therefore generate families of 
potentially useful analogues that are inaccessible by chemical synthesis. These 
results also encourage the belief that other domains may be similarly swapped. 
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Introduction 
Complex polyketides are natural products, found pre- 
dominantly in Strepto~nyces and related filamentous 
bacteria, that exhibit an impressive range of antibiotic, 
anticancer, anti-parasite and immunosuppressant activ- 
ities. They are synthesized by a common pathway, in 
which units derived from acetate, propionate and 
(occasionally) butyrate are condensed onto the growing 
chain, in a process resembling fatty acid biosynthesis [1,2]. 
The intermediates remain bound to the polyketide 
synthase (PKS) during multiple cycles of chain extension 
and (to a variable extent) reduction of the P-keto group 
formed in each condensation. The structural variation 
between naturally occurring polyketides arises largely 
from the way each PKS controls the number and type of 
units added, and the extent and stereochemistry of 
reduction at each cycle. In addition, the product of the 
PKS is frequently acted upon by regiospecific glycosyl- 
ases, methyltransferases and oxidative enzymes, to produce 
still greater diversity. 
Complex reduced polyketides such as the macrolides and 
polyethers are synthesized in bacteria on multifunctional 
PKSs that contain a separate set, or module, of enzymatic 
activities for every round of chain extension [3-7). For 
example, the clinically-important antibiotic erythromycin 
A is derived from propionyl-Cob and six molecules of 
(ZS)-methylmalonyl-CoA [S], through the sequential 
action of six such sets of enzymes housed in the three 
multienzyme polypeptides [9] of 6-deoxyerythronolide B 
synthase (DEBS) (Fig. 1). The most remarkable example 
so far studied is the PKS for the immunosuppressant 
rapamycin from Streptomyces hygroscop&s, which contains 
14 modules housed in only 3 huge multienzyme 
polypeptides [lo]. In contrast to the modular type I PKS 
multienzymes, bacterial aromatic polyketides are 
synthesized by type II PKSs, comprising a single set of 
enzymes housed in separate proteins [l l-141. 
Considerable interest has developed in the possibility of 
generating hybrid polyketides by suitable combination of 
activities from different natural polyketide synthases. In 
pioneering experiments, Strohl and colleagues [15,16] 
showed that when portions of the act biosynthetic gene 
cluster of Sfrept0myce.s coeLicoLor, encoding the type II PKS, 
were introduced into anthracycline-producing strains of 
Streptomyces gaMeus, novel polyketide metabolites were 
produced, whose structures demonstrated that productive 
hybrid type II PKSs were indeed formed. A large number 
of such experiments have since been systematically 
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Figure 1 
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Modular PKSs and their products. (a) 
Domain organization of the truncated triketide 
lactone synthase derived from DEBS. Each 
protein module contains an acyl carrier 
protein (ACP), an acyltransferase (AT), a 
8-ketoacyl-ACP synthase (KS), and a 
8-ketoacyl-ACP reductase (KR). The 
thioesteraselcyclase (TE), which normally 
cyclizes the full-length chain to 
6-deoxyerythronolide B, is fused to the 
carboxyl terminus of DEBS 1. Cyclization at 
this stage is predicted to produce the 
triketide lactones 1A and 1 B. The 
acyltransferase domain of module 1 (ATl), 
which is specific for methylmalonyl-CoA, is 
highlighted together with that part of the 
growing chain directly affected by the 
activities of module 1. (b) Domain 
organization of RAPSl, the first multienzyme 
component of the rapamycin-producing PKS 
[10,281. Certain modules contain 
enoylreductase (ER) and dehydratase (DH) 
domains in addition to those found in the 
DEBS proteins. The acyltransferase domain 
of module 2 of the rap PKS (AT2), which is 
specific for malonyl-CoA, is highlighted 
together with that part of the growing chain 
directly affected by the activities of module 2. 
(c) Domain organization of the hybrid 
triketide lactone synthase TKScaml 1, 
constructed by replacing almost the entire 
AT1 domain of DEBSl -TE by rap AT2, 
together with the predicted products of the 
hybrid enzyme (2A and 2B). 
carried out in other laboratories [17-211 leading to the 
formulation of ‘design rules’ for production of novel 
aromatic polyketides [Zl], and to a better understanding of 
the role of individual components of the PKS. However, 
by no means every combination is productive [Zl], and the 
reasons for this remain obscure. To perform the 
counterpart of such ‘mix and match’ experiments with a 
modular PKS and study the design rules for these 
enzymes would require genetic engineering to replace an 
individual domain of the multienzyme by an analogous 
domain from another type I PKS (or fatty acid synthase) 
that might confer an altered specificity. We have 
investigated whether this is possible using our previously 
described model system [‘ZZ] in which a chain-terminating 
cyclase domain (TE) has been fused to the carboxyl 
terminus of DEBSl, the multienzyme that catalyzes the 
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first two rounds of polyketide chain extension in 
erythromycin biosynthesis. The chimaeric DEBSl-TE 
was shown to synthesize efficiently the triketide lactone 
1B in Sacc&ropoJys$ora erythrueu [ZZ] and both IA and 1B 
in S. coelicolor [23,24]. This approach has been successfully 
used to produce other chain lengths by truncation of 
DEBS [25]. 
We chose to replace the acyltransferase (AT) domain 
within module 1 of DEBSl-TE, the domain responsible 
for incorporation of a methylmalonyl extender unit during 
the first cycle of polyketide chain extension (Fig. 1). Such 
AT domains are present in every module and are believed 
to form part of the structural core of a modular PKS 
[26,27]. They are highly homologous as judged from 
sequence comparisons [‘28], but within this overall 
homology there are discernible sequence differences 
between those AT domains that recruit an acetate unit 
from malonyl-CoA and those AT domains that recruit a 
propionate unit from methylmalonyl-CoA (Fig. 2) [29]. 
We report here the results of specific replacement of the 
entire propionate-specific AT1 domain in DEBSl-TE 
with its acetate-specific counterpart from module 2 of the 
rapamycin-producing PKS (Fig. l), and characterization of 
the products of the resulting hybrid modular PKS. 
Results and discussion 
Construction of the gene encoding the hybrid triketide 
synthase TKScamll 
The starting point for construction of the chimaeric gene 
was a pT7-7-based plasmid housing the entire open 
reading frame for the DEBSl-TE gene. There are only 
two &ZLI restriction sites within this gene, which flank the 
target DNA encoding the AT1 domain. The cloning 
strategy, as detailed in Materials and methods, was 
Figure 2 
Alignment of the sequences of 
acyltransferase domains. The ATI of DEBSl 
is aligned with AT2 of the rapamycin- 
producing PKS. Identical residues are shown 
in red. Also shown are the divergent 
sequence motifs identified for acetate- 
specific AT domains (blue) and for 
propionate-specific AT domains (yellow). The 
positions of the newly introduced restriction 
sites for Bail and Avrll are indicated. 
therefore to exchange the SLZLI fragment for a new 
fragment into which the desired changes to the AT 
domain had been introduced (Fig. 3). In plasmid plMO5 
the StzlI fragment consists of, first, a PCR-generated 
Stul-Ball fragment, which extends to just inside the 
amino-terminal end of AT1 and introduces a unique BaA 
site without affecting the amino acid sequence (Fig. 2); 
and second, a PCR-generated fragment flanked by Bafl 
and A~11 sites on one end and a StuI site at the other, and 
encoding the extreme carboxyl terminus of ATl. The 
DNA encoding the new AT domain derived from 
rapamycin module 2 is excised from plasmid pMOZ and 
ligated into pM0.5 as a B&I-AvrII fragment, to produce 
plasmid pDl-AT,, encoding a full-length, heterologous 
AT domain (Fig. 3). All PCR products were fully 
sequenced to check their integrity. 
The vector used for expression of the hybrid gene in S. 
coelicalor was based on the useful bifunctional SCPZ”- 
based low copy number S. co&color plasmid pRM5, 
developed by Khosla, Hopwood and colleagues [17], in 
which genes are placed under the control of the a& 
promoter. The modified plasmid contains unique A&I and 
XbaI sites downstream of the uct( promoter, into which the 
altered PKS gene, encoding the hybrid PKS (TKScamll) 
was conveniently cloned as an NdeI-XhaI fragment (Fig. 
3). The resulting expression plasmid pRM-AT2 was trans- 
formed into S. coelicolor CH999, a strain lacking the 
actinorhodin biosynthetic genes [ 171. 
Polyketide production in vivo by the hybrid polyketide 
synthase TKScamll 
Previously, an engineered strain of S. coelicolor containing 
the DEBSl-TE multienzyme has been shown to produce 
a mixture of triketide lactones IA and 1B (Fig. l), with 
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Figure 3 
Xbal Nde 
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Xbal 13.4g.,NdelO.O0 
fragment of 
pMO2, containing Xbal 11 
AT2 from RAPS1 
Ball 
* 
/ 
Ligation of 11 .Zkb 
Ndel - Xbal fragment 
into pRMS2 
Construction of an expression plasmid 
containing the chimaeric polyketide synthase 
gene. Plasmid pM05 is a pT7-based plasmid 
in which the complete open reading frame for 
DEBSl -TE is shown as an Ndel-Xbal 
fragment. The Stul-Ball fragment and the 
Avrll-Stul fragments encode the regions 
flanking the AT1 domain. The insertion of the 
Ball-Avrll fragment containing the AT2 
domain of the rap PKS yields plasmid 
pD1 -AT,, containing the desired chimaeric 
gene. The gene is then subcloned into the 
SCPP*-derived vector pRM52 to produce 
the expression plasmid pRM-AT2. 
1A being the major product [23]. For reasons that remain broth of S. coelicolor expressing the hybrid multienzyme 
unclear, DEBSl alone, when overproduced using the TKScamll showed the complete absence of peaks 
identical system in S. coelicolor, is reported by others to corresponding either to 1A or 1B. In their place, two new 
produce 1B only [30]. In the present study, gas chroma- peaks were observed (Fig. 4) which on further analysis 
tography (CC) analysis of extracts from the fermentation were shown to correspond to the novel lactones 2A and 
Figure 4 
GC analysis of polyketide products of 
TKScaml 1. The retention times for the 
lactones under the conditions used are as 
follows: 11.85 min (IA); 12.90 min (1B); 
10.38 min (2A) (magenta); and 11.75 min 
(cyan) (26). The ordinate shows intensity of 
signal in arbitrary units. 
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2B (Fig. l), formed in roughly equal amount, and arising 
from the use of, respectively, acetate or propionate as a 
starter unit for the PKS [31,32]. The identity of the 
purified novel lactones was fully established by high 
resolution electrospray mass spectrometry, and by ‘H and 
13C NMR. The clear conclusion from these data is that 
the domain swap has successfully (and completely) altered 
the nature of the extension unit recruited by AT1 of the 
synthase, from a propionate to an acetate unit. There is no 
evidence, under the conditions used, for the formation of 
other diastereoisomers of 2A and 2B, so it appears that 
other events on the synthase catalyzed by module 1, 
particularly the reduction of the B-ketoacyl group, are not 
influenced by the engineered change. Similarly, module 2 
has correctly processed the altered chain. The total yield 
of triketide lactone is also not greatly altered compared to 
that from DEBSl-TE in S. coelicolor under the same 
conditions [23]. 
As indicated in Figure 1, the normal context of the AT 
domain of module 2 is within the four-module multi- 
enzyme subunit RAPS1 of the rapamycin-producing poly- 
ketide synthase [10,28]. Module 2 of RAPS1 accomplishes 
the incorporation of an acetate unit and its reduction to a 
hydroxyacyl thioester, and this made it a reasonable choice 
to replace the AT1 of DEBSl-TE, which incorporates a 
propionate unit and likewise reduces it to a hydroxyacyl 
thioester. The success of this domain swap does not allow 
us to claim that any AT domain can be replaced by any 
other, since other pairs of AT domains may have a normal 
context which is less favourably matched. However, given 
the relatively high degree of sequence identity between AT 
domains from different modular PKSs, this result does hold 
out the promise that any complex polyketide in which 
propionate units occur might be engineered in an analogous 
fashion, to create a derivative specifically lacking one or 
more branching methyl groups. If this approach can indeed 
be generalized, it will conveniently make available 
derivatives of known antibiotics that would be hard to 
obtain by chemical synthesis. If the approach of domain 
swapping can also be extended to the other constituent 
domains of the PKS, such as the ketosynthases and keto- 
reductases, then the number of novel modified polyketides 
brought within reach would be very large indeed. 
Significance 
The modular type I polyketide syntbases of Streptomyces 
and related Gram-positive bacteria constitute a unique 
family of carbon chain-forming multienzymes respon- 
sible for the biosynthesis of a large number of struc- 
turally diverse natural products, including antibiotics 
and immunosuppressants. 
manipulation to relocate the cyclase/thioesterase domain 
from DEBS3 to the carboxyl terminus of DEBSl. 
Strains of S. erythraea 1221 and S. coelicolor [23,24] 
bearing the fused DEBSl-thioesterase efficiently 
accumulate the anticipated triketide lactones. 
We have now shown that another type of PKS domain 
can function in a different context; the methylmalonyl- 
CoA:ACP acyltransferase domain from within exten- 
sion module 1 of the DEBSl-TE has been wholly 
replaced by an acyltransferase domain derived from 
module 2 of the rapamycin-producing polyketide syn- 
thase, without loss of function. The newly-introduced 
domain is specific for malonyl-CoA, and we have found 
that the chimaeric PKS catalyzes, as predicted, insertion 
of an acetate unit into the triketide lactone product in 
place of one of the propionate units. The ability to swap 
domains between different modular polyketide syn- 
thases to form productive hybrids is a key step towards 
using these multienzymes to generate novel polyketides 
of potential utility as lead compounds in drug discovery. 
Materials and methods 
Strains and plasmids 
E. co/i TGlrecO was maintained on MS minimal medium [331 
supplemented with thiamine. S. coelicolor CH999 was maintained on 
solid tap water medium [341. SCPP*-based plasmids were selected for 
using thiostrepton, the kind gift of E.J. Lucania (Squibb). 
DNA manipulations 
Routine cloning and transformation procedures were as previously 
described for E. co/i [33] and for Streptomyces 1351. PCR was carried 
out by the method of Saiki et al. 1361. 
Construction of plasmid pRM52 
Plasmid pRM52 is a derivative of plasmid pRM5 [i 71. Plasmid pRM5 
was first linearized by digestion with Ndel, end-repaired and then 
religated to produce pRM51. pRM51 was cut with Pacl and Nsil and 
the large Pacl-Nsil fragment was isolated and ligated to a short double- 
stranded oligonucleotide linker containing an Wel site and constructed 
from the synthetic oligonucleotides 5’-TAAGGAGGACACATATGCA-3’ 
and 5’.TAATTCCTCCTGTGTAT-3’, which were annealed together. The 
ligation mixture was transformed into E. co/i TGl rec0 and isolated 
colonies were screened for their plasmid content. The desired plasmid 
(19.6 kb) was identified by its restriction map, and designated pRM52. 
Construction of expression plasmid pRM-AT2 
This was constructed in several stages, as follows. The -1.3 kb DNA 
segment of the eryA/ gene of S. erythraea extending from nucleotide 
1 948 to nucleotide 3 273 of eryA/ [4] was amplified by PCR using as 
primers the synthetic oligonucleotides 5’.CATGCTCGAGCTCTCCTG- 
GGAAGT-3’ and 5’-CAACCCTGGCCAGGGAAGACGAAGACGG-3’, 
and the plasmid pNTEP2 as template. Plasmid pNTEP2 is a pT7-7- 
based plasmid from which the entire open reading frame for the DEBSl- 
TE gene can be excised as an Ndel-Xbal fragment, and the details of its 
construction will be given elsewhere. The PCR product was end- 
repaired and ligated into Smal-digested, phosphatase-treated plasmid 
pUC18, and used to transform E. co/i TGl rec0. The desired plasmid 
(pMO1) has the Stul site adjacent to the HindIll site in the polylinker. The 
We have recently introduced a method of specifying 0.85 kb segment of the rapA gene of S. hygroscopicus, extending from 
the length of polyketide chain released from a modu- 
nucleotide 1 1 392 to nucleotide 12 235 of rapA [I 01, was amplified by 
PCR usina the oliaonucleotides 5’-TTCCCTGGCCAGGGGTCGCAGC- 
lar polyketide synthase, and illustrated it by genetic GTG-3’ and 5’-CACCTAGGACCGCGGACCACTCGAC-3’ as primers, 
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and the DNA from the recombinant bacteriophage X-l C [lo] as the 
template. The PCR product was end-repaired and ligated into Smal- 
cut pUC18, and transformed into E. co/i TGlrecO. The desired 
plasmid (pM02) was identified by its restriction pattern. The 1.7 kb 
DNA segment of the eryA/ gene of S. erythraea extending from 
nucleotide 4 128 to nucleotide 5 928 of eryA/ [41 was amplified by 
PCR using the synthetic oligonucleotides 5’-TGGCCAGGGAG- 
TCGGTGCACCTAGGCA-3’ and 5’-GCCGACAGCGAGTCGA- 
CGCCGAGTT-3’ as primers, and plasmid pNTEP2 as template. The 
PCR product was end-repaired and ligated into Smal-cut pUC18, 
and the ligation mixture was transformed into E. co/i TGl rec0. The 
desired plasmid (pM03) has Ball and Avrll sites adjacent to the 
Hindlll site of the polylinker. Plasmid pMO1 was digested with 
HindIll and Ball and the insert was ligated into plasmid pM03 which 
had been digested with HindIll and Ball, to produce plasmid pM04. 
Plasmid pM04 was then digested with Stul and the 3.0-kb insert 
was used to replace the Stul fragment present in plasmid pNTEP2, 
to create plasmid pM05 (Fig. 3). Plasmid pM02 was digested with 
Ball and Avrll and the insert was ligated into plasmid pM05 which 
had been cut with the same two enzymes to produce plasmid pDl- 
AT, (Fig. 3). The hybrid PKS gene was excised from pD1 -AT, as an 
Ndel-Xbal fragment and ligated into pRM52 which had been 
similarly cut with Ndel and Xbal, to produce the expression plasmid 
pRM-AT2 (Fig. 3). 
Purification of (2S,3R,5R)-2-methyl-3,5-dihydroxy-n-heptanoic 
acid S-lactone and (2S,3R,5R)-2-methyl-3,5-dihydroxy-n- 
hexanoic acid Hactone 
S. coelicolor (pRM-AT2) was grown in 3 x 500 ml YEME medium 
(without sucrose) for 5 days in the presence of thiostrepton 
(10 mg I-‘). The medium was filtered and extracted with 3 volumes of 
ethyl acetate, yielding 220 mg of crude product. This was absorbed 
onto silica (0.5 g) and partially purified by flash column chromato- 
graphy (15 x 1 cm, diethyl ether). Fractions containing triketide lac- 
tones were pooled and purified by HPLC (Beckman Ultrasphere ODS 
5p, 10.0 x 250 mm, eluted isocratically at 2 ml min-’ with 25 O/o 
MeOH: O/o H,O for 5 min followed by a linear gradient to 45 O/o 
MeOH: O/a H,O over 25 min. (2S,3R,5R)-2-methyl-3,5-dihydroxy-n- 
hexanoic acid &lactone (2A) has a retention time of 11 min, and 
(2S,3R,5/?)-2-methyl-3,5-dihydroxy-n-heptanoic acid &lactone (26) 
has a retention time of 18 min. The yield of purified 2A was 1.5 mg I-‘, 
and that of 26 was 2.0 mg I-‘. 
Characterization of (2S, 3R, 5R)-2-methyl-3,5-dihydroxy-n- 
hexanoic acid S-la&one @A) 
‘H NMR (CDCI,, 400 MHz) 6H 4.36 (lH, dqd, J = 11.9, 6.6, 3.1 Hz, 
H-5), 3.75 (1 H, ddd, J = 11.3, 9.9, 3.7 Hz, H-3), 2.32 (1 H, dq, J = 9.9, 
6.8 Hz, H-2), 2.20 (lH, ddd, J = 13.3, 3.7, 3.1 Hz, H-4,,), 1.65 (lH, 
ddd, J = 13.3, 11.9, 11.3 Hz, H-4,,), 1.40 (3H, d, J = 6.6 Hz, CH,-2’), 
1.40 (3H, d, J = 6.6 Hz, CH,-6) ppm. High-resolution electrospray 
mass spectrometry (HRMS) calc’d for C,H,,O,: 145.08647, found 
(M+H)+ 145.08728 (+5.60 ppm). 
Characterization of (2S, 3R, 5R)-2-methyl-3,5-dihydroxy-n- 
Aeptanoic acid S-la&one (28) 
‘H NMR (CDCI,, 400 MHz) 6H 4.18 (1 H, dtd, J = 11.8, 6.1, 2.9 Hz, 
H-5), 3.75 (1 H, ddd, J = 11.0, 10.0, 4.0 Hz, H-3), 2.35 (1 H, dq, J = 
10.0, 7.0 Hz, H-2), 2.20 (1 H, ddd, J = 13.3, 4.0, 2.9 Hz, H-4,,), 
1.6-1.8 (3H, m, 2xH-6, H-4,,), 1.41 (3H, d, J = 7.0 Hz, CHs-2’), 1.01 
(3H, t, J = 7.5 Hz, CHa-7) ppm. 13C NMR (CDCI,, 100 MHz) 6C 173.3 
(C-l), 77.7 (C-5), 70.4 (C-3), 45.1 (C-2), 37.7 (C-4), 28.8 (C-6), 13.5 
(C-2’), 9.1 (C-7) ppm. HRMS calc’d for C,H,,O,: 159.10212, found 
(M+H)+ 159.10361 (+9.37 ppm). 
Structural assignments were obtained for (2S,3/?,5R)-2-methyl-3,5- 
dihydroxy-n-hexanoic acid 6-lactone (compound 2A) and for (2S,3/?,5R)- 
2-methyl-3,5-dihydroxy-n-heptanoic acid &lactone (compound 2B) using 
correlation spectroscopy (COSY), heteronuclear multiple bond corre- 
lation (HMBC) and heteronuclear multiple quantum coherence (HMQC) 
and 2D NMR spectroscopy (data not shown). Vicinal coupling constants 
for ring protons confirmed the assigned stereochemistry and were within 
0.5 Hz of those predicted for molecular models minimized using the 
MM2 force-field 1371 with MacroModel (version 5.5) [38]. Coupling 
constants were calculated using the algorithm of Haasnoot et al. [39]. 
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